Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Factor VIII deficiency

Not recruiting

InvestigationalNo placebo

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Heart failure with reduced ejection fraction

Not recruiting

Investigational

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational

France

Participants:18–64 years · 65+ years
Substances:Vericiguat

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Investigational

France

Participants:18–64 years · 65+ years
Substances:3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid

Contact Research Centre

Haemophilia

Not recruiting

Registered drugNo placebo

Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Fitusiran

Contact Research Centre

Factor VIII deficiency+3

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years

Contact Research Centre

Find therapies in clinical trials near you – page 24

296 trials match your criteria

Pulmonary arterial hypertension

Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

Hypoparathyroidism

Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

Juvenile idiopathic arthritis

Study on Filgotinib for Children and Teens with Juvenile Idiopathic Arthritis

Hypophosphatasia

Study on Immunosuppressive Therapies with Asfotase Alfa for Patients with Hypophosphatasia Experiencing Reduced Treatment Effectiveness

Premature rupture of membranes

Study Comparing Balloon with Oxytocin and Oral Misoprostol for Inducing Labor in First-Time Mothers with Premature Rupture of Membranes at Term

Pulmonary hypertension

Study on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD

Factor VIII deficiency

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

Heart failure with reduced ejection fraction

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Colitis ulcerative

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Pulmonary arterial hypertension

Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Haemophilia

Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

Factor VIII deficiency+3

Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.